Enanta Pharmaceuticals | ENTA - EPS Earnings Per Share


Enanta Pharmaceuticals reported $-1.05 in EPS Earnings Per Share for its fiscal quarter ending in December of 2024.





Eps Change Date
AbbVie USD 3.82 0.17 Sep/2026
Amgen USD 6.45 0.16 Sep/2026
Anika Therapeutics USD 0.13 0.35 Dec/2025
Arrowhead Research USD -1.36 0.43 Jun/2026
AstraZeneca USD 2.79 0.16 Sep/2026
BioCryst Pharmaceuticals USD 0.3 0.87 Jun/2026
Biogen USD 2.62 0.98 Sep/2026
Bristol-Myers Squibb USD 1.35 0.69 Sep/2026
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 2.55 9.3 Sep/2026
GlaxoSmithKline GBP 0.55 0.04 Sep/2026
Halozyme Therapeutics USD 2.39 0.11 Sep/2026
Heron Therapeutics USD -0.02 0.02 Dec/2025
Immunic USD -0.1 0.03 Dec/2025
Incyte USD -3.6 6.69 Sep/2026
Insmed USD -0.46 0.4 Sep/2026
Ionis Pharmaceuticals USD -0.69 0.13 Jun/2026
J&J USD 2.7 0.2 Sep/2026
Karyopharm Therapeutics USD -1.02 1.2 Mar/2026
Ligand Pharmaceuticals USD 2.67 0.3 Sep/2026
Merck USD 2.49 2.62 Sep/2026
Neurocrine Biosciences USD 3.29 0.44 Sep/2026
Novartis USD 2.46 0.05 Sep/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.87 0.1 Sep/2026
PTC Therapeutics USD -0.62 1.54 Sep/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sarepta Therapeutics USD 0.13 0.51 Sep/2026
Vertex Pharmaceuticals USD 4.76 0.03 Sep/2026